The absence of information regarding the role of Ikaros in the myeloid context led us evaluate differences and similarities between these two groups; reorganizing our original pathologies and forming two new groups: lymphoid (B-ALL, CLL and MM) and myeloid (AML and CML). Here, IKZF1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.